Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L5 pseudogene 2 (RPL5P2) is a non-coding genetic element derived from the ribosomal protein L5 gene (RPL5). Pseudogenes like RPL5P2 are genetic sequences similar to known genes but typically lack protein-coding functionality due to the accumulation of mutations or deletion of regulatory regions. RPL5P2 is annotated as a processed pseudogene, meaning it arose by reverse transcription of RPL5 mRNA followed by genomic integration, but it does not contribute to ribosomal function or any known cellular processes. RPL5P2 is not an active gene and does not encode the ribosomal protein L5. The functional gene encoding ribosomal protein L5 is RPL5, which is involved in ribosome assembly and intracellular transport of 5S rRNA. RPL5P2 is one of several pseudogenes for RPL5, and as such, it is not typically considered a therapeutic target, nor associated with molecular functions, disease roles, or interactions relevant to drug discovery. Unlike the functional RPL5 gene, which has roles in ribosome biogenesis, protein synthesis, and has been implicated in diseases such as Diamond-Blackfan anemia and certain cancers, RPL5P2 does not have known biological functions, disease associations, or usage as a biomarker. Pseudogenes seldom produce functional protein products, and RPL5P2 fits this definition; therefore, its inclusion as a therapeutic target would be scientifically incorrect. If you are interested in the functional ribosomal protein L5, please refer to the canonical gene (RPL5), which has well-defined roles in human biology and disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L5 pseudogene 2 (RPL5P2).